Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries.

Piramal Pharma Limited offers a portfolio of innovative healthcare solutions through end-to-end manufacturing capabilities across 14 global facilities and a global distribution network in over 100 countries.

Piramal Pharma Solutions offers integrated drug discovery, development, and manufacturing services across global facilities, ensuring innovative solutions and quality for all stages of the drug lifecycle.

Learn about Piramal Pharma Solutions, a global CDMO providing end-to-end drug development, manufacturing, and specialized pharma solutions worldwide.

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate. In the early 1980s, Ajay Piramal took over the reins of Piramal Group.

Discover Piramal Pharma Limited's extensive network and cutting-edge facilities. Explore how their robust network and advanced facilities ensure unmatched quality and efficiency, making Piramal Pharma Limited a leading name in the pharmaceutical industry.

Piramal Group is a leading Global Business Conglomerate with diverse interests in Pharma, Financial Services, Real Estate, and Glass Packaging; nurturing social initiatives through Piramal Foundation

20 hours ago · In today's session, Piramal Pharma experienced a notable surge, climbing 4.85% to reach Rs 230.20. This increase was accompanied by significantly higher trading volumes compared to the average ...

Oct 4, 2022 · Piramal Pharma Share Price: Find the latest news on Piramal Pharma Stock Price. Get all the information on Piramal Pharma with historic price charts for NSE / BSE.

5 days ago · Piramal Critical Care is a division of Piramal Pharma and a global leader in anaesthesia, pain management, intrathecal therapy, and critical care medicine. Shares of Piramal Pharma Ltd ended at ₹221.25, up by ₹2.75, or 1.26%, on the BSE. Also Read: Piramal Pharma's Mumbai facility gets 6 observations from US FDA inspection